Authors
Loading...
Review demonstrates how JAK-STAT signaling mediates immune and oncologic diseases, highlighting the clinical promise of targeted kinase inhibitors.
O’Shea et al. (2015) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: